share_log

Goldman Sachs Maintains Buy on Teradyne, Raises Price Target to $161

Benzinga ·  May 28 23:51

Goldman Sachs analyst Toshiya Hari maintains Teradyne (NASDAQ:TER) with a Buy and raises the price target from $118 to $161.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment